Research Article
Gastrointestinal Dysfunctions Are Associated with IL-10 Variants in Parkinson’s Disease
Table 1
Demographic data and clinical characteristics of PD patients in both IL-10 rs1800871 and rs1800872 carriers and noncarriers (numerical variables).
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: UPDRS I, II, III, Unified Parkinson’s Disease Rating Scale part I, II, III; H-Y, Hoehn and Yahr Scale; LEDD, Levodopa equivalent daily dose; PDSS, Parkinson’s Disease Sleep Scale; NMSS, Nonmotor Symptoms Scale; NMSS-D1, NMSS-cardiovascular; NMSS-D2, NMSS-sleep/fatigue; NMSS-D3, NMSS-mood/apathy; NMSS-D4, NMSS-perception/hallucinations; NMSS-D5, NMSS-attention/memory; NMSS-D6, NMSS-gastrointestinal; NMSS-D7, NMSS-urinary; NMSS-D8, NMSS-sexual dysfunction; PDQ-39, the 39-item Parkinson’s Disease Questionnaire; CCI, Charlson Comorbidity Index. N represented the total number of carriers and noncarriers of both IL-10 rs1800871 and rs1800872 in PD patients. Numerical variable was presented as mean and standard deviation (X ± S). values <0.05 were considered of statistical significance and was shown in boldface text. SC, standardized coefficient; NA, not available. |